JC: The UK-REBOA trial. Has the balloon popped? St Emlyn’s
Zaf Qasim @resusone reviews the UKREBOA trial. No benefit shown, but is this really the end of REBOA in trauma? #FOAMed @stemlyns
Zaf Qasim @resusone reviews the UKREBOA trial. No benefit shown, but is this really the end of REBOA in trauma? #FOAMed @stemlyns
Despite the socializing and “Stand-Up Science” events that ran pretty late into the night, there was no holding back the full cohort of attendees for Day 2 of LTC. Let’s …
What did we learn at the London Trauma Conference 2022 – Part Two Read More »
Part 1 review of the 2022 London Trauma Conference with Zaf @resusone #FOAMed @stemlyns
Resuscitative thoracotomy remains a controversial procedure in prehospital and emergency care. This month we have more evidence of its effectiveness in prehospital care. Despite significant advances in trauma care, we …
JC: Pre-hospital thoracotomy – what can we learn? St Emlyn’s Read More »
This post is co-published with our friends at REBEL EM. Background: It almost seems that when it comes to the use of the antifibrinolytic agent tranexamic acid (TXA) in trauma, …
A little while ago I reported from the American Association for the Surgery of Trauma’s meeting – specifically covering the management of major – or mass casualty – incidents (MCI). …
Ed – this blog is co-published on the REBEL EM site here. http://rebelem.com/jc-time-to-put-the-reboa-balloon-away-maybe-maybe-not/ The management of the critically hemorrhaging trauma patient has seen a large amount of change over last …
JC: Time to put the REBOA balloon away? Maybe, maybe not… Read More »
One thing is clear from the military and civilian literature – hemorrhage kills1,2. Overall, 40-50,000 deaths per year in the US are preventable with appropriate hemorrhage control and resuscitation. The …
Everything old is new again – whole blood in the trauma bay – St Emlyn’s Read More »